Summary A temporary gut liner implant, EndoBarrier, has shown promising results in treating type 2 diabetes and obesity. The device promotes weight loss, improves glycemic control, and reduces the need for insulin in many patients. […]
Summary This article discusses the FDA warning letter issued to Dexcom regarding unauthorized changes to their glucose monitors. Dexcom refutes the FDA’s claims, stating they only qualified a second raw material source and didn’t change […]
Summary This article explores common medications known to elevate blood glucose levels, impacting diabetes management. We delve into the mechanisms behind these effects and discuss strategies for mitigating risks. Understanding these potential side effects empowers […]
Summary A groundbreaking stem cell transplant has allowed a type 1 diabetes patient to produce insulin, potentially eliminating the need for injections. This world-first procedure used the patient’s own cells, minimizing the risk of rejection […]
Summary New research shows electrical stimulation of cells improves insulin response in type 2 diabetes, potentially offering a new treatment approach. This breakthrough involves regenerating cells in the gut related to blood sugar control using […]
Summary Smart insulin, currently under development, promises to revolutionize diabetes management by automatically adjusting to blood glucose levels, minimizing the need for constant monitoring and injections. This advancement offers hope for better blood sugar control, […]
Summary This article explores Rwanda’s innovative approach to managing type 1 diabetes in youth, focusing on digital health advancements and educational camps. The integrated strategy emphasizes patient empowerment, data-driven insights, and community support. It highlights […]
Summary The ATTD 2025 conference in Amsterdam showcased exciting advancements in diabetes management, including improved AID systems, more accurate and longer-lasting CGMs, and smart insulin pens. These technologies aim to simplify diabetes management and improve […]
Summary Medtronic’s Smart MDI system aims to simplify diabetes management and minimize glucose highs for people using multiple daily injections (MDI). The system combines the InPen smart insulin pen with the Simplera continuous glucose monitor […]
Summary Sequel MedTech and Abbott partner to integrate CGM technology with automated insulin delivery. This collaboration aims to enhance diabetes management by combining Sequel’s twiist AID system with Abbott’s FreeStyle Libre 3 Plus sensor. The […]
© 2025 Newsguru LTD. All rights reserved.